Environmental stress affects the activity of metabolic and growth factor signaling networks and induces autophagy markers in mcf7 breast cancer cells

Molecular and Cellular Proteomics

Volumn 13, Issue 3, 2014, Pages 836-848

  Casado, Pedro ^a,b   Bilanges, Benoit ^b   Rajeeve, Vinothini ^a,b   Vanhaesebroeck, Bart ^b   Cutillas, Pedro R ^a,b  

^a Analytical Signalling Group   (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR 2 KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPEPTIDE; PROTEIN KINASE; PROTEIN KINASE B; S6K KINASE; ULK1 KINASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; BREAST CANCER; CANCER CELL; CATABOLISM; CELL METABOLISM; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; ENVIRONMENTAL STRESS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; METABOLIC STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; AUTOPHAGY; BREAST NEOPLASMS; ENVIRONMENT; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MCF-7 CELLS; MOLECULAR SEQUENCE DATA; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOPEPTIDES; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TEMPERATURE; TUMOR MARKERS, BIOLOGICAL;

EID: 84895546634     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.034751     Document Type: Article

References (74)

1. Manning, G., Plowman, G. D., Hunter, T., and Sudarsanam, S. (2002) Evolution of protein kinase signaling from yeast to man. Trends Biochem. Sci 27, 514-520
2. Bahk, Y. Y., Mohamed, B., and Kim, Y. J. Biomedical application of phosphoproteomics in neurodegenerative diseases. J. Microbiol. Biotechnol. 23, 279-288
3. Grimsrud, P. A., Carson, J. J., Hebert, A. S., Hubler, S. L., Niemi, N. M., Bailey, D. J., Jochem, A., Stapleton, D. S., Keller, M. P., Westphall, M. S., et al. A quantitative map of the liver mitochondrial phosphoproteome reveals posttranslational control of ketogenesis. Cell Metab. 16, 672-683
4. Iwai, L. K., Benoist, C., Mathis, D., and White, F. M. Quantitative phosphoproteomic analysis of T cell receptor signaling in diabetes prone and resistant mice. J. Proteome Res. 9, 3135-3145
5. Solit, D. B., and Mellinghoff, I. K. Tracing cancer networks with phosphoproteomics. Nat. Biotechnol. 28, 1028-1029
6. Di Domenico, F., Sultana, R., Barone, E., Perluigi, M., Cini, C., Mancuso, C., Cai, J., Pierce, W. M., and Butterfield, D. A. Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects. J. Proteomics 74, 1091-1103
7. Hsu, P. P., Kang, S. A., Rameseder, J., Zhang, Y., Ottina, K. A., Lim, D., Peterson, T. R., Choi, Y., Gray, N. S., Yaffe, M. B., et al. The mTORregulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317-1322
8. Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., 3rd, Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) ATM and ATR substrate analysis reveals extensive protein net-works responsive to DNA damage. Science 316, 1160-1166
9. Courcelles, M., Fremin, C., Voisin, L., Lemieux, S., Meloche, S., and Thibault, P. Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions. Mol. Syst. Biol. 9, 669
10. Kim, J. Y., Welsh, E. A., Oguz, U., Fang, B., Bai, Y., Kinose, F., Bronk, C., Remsing Rix, L. L., Beg, A. A., Rix, U., et al. Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells. Proc. Natl. Acad. Sci. U.S.A. 110, 12414-12419
11. Klammer, M., Kaminski, M., Zedler, A., Oppermann, F., Blencke, S., Marx, S., Muller, S., Tebbe, A., Godl, K., and Schaab, C. Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol. Cell. Proteomics 11, 651-668
12. Metodiev, M., and Alldridge, L. (2008) Phosphoproteomics: A possible route to novel biomarkers of breast cancer. Proteomics Clin. Appl. 2, 181-194
13. Alcolea, M. P., Casado, P., Rodriguez-Prados, J. C., Vanhaesebroeck, B., and Cutillas, P. R. (2012) Phosphoproteomic analysis of leukemia cells under basal and drug-treated conditions identifies markers of kinase pathway activation and mechanisms of resistance. Mol. Cell. Proteomics 11, 453-466
14. Casado, P., Alcolea, M. P., Iorio, F., Rodriguez-Prados, J. C., Vanhaesebroeck, B., Saez-Rodriguez, J., Joel, S., and Cutillas, P. R. Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors. Genome Biol. 14, R37
15. Lim, Y. P. (2005) Mining the tumor phosphoproteome for cancer markers. Clin. Cancer Res. 11, 3163-3169
16. Skold, K., Alm, H., and Scholz, B. The impact of biosampling procedures on molecular data interpretation. Mol. Cell. Proteomics 12, 1489-1501
17. Espina, V., Edmiston, K. H., Heiby, M., Pierobon, M., Sciro, M., Merritt, B., Banks, S., Deng, J., VanMeter, A. J., Geho, D. H., et al. (2008) A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Mol. Cell. Proteomics 7, 1998-2018
18. Svensson, M., Boren, M., Skold, K., Falth, M., Sjogren, B., Andersson, M., Svenningsson, P., and Andren, P. E. (2009) Heat stabilization of the tissue proteome: a new technology for improved proteomics. J. Proteome Res. 8, 974-981
19. Virshup, D. M., Eide, E. J., Forger, D. B., Gallego, M., and Harnish, E. V. (2007) Reversible protein phosphorylation regulates circadian rhythms. Cold Spring Harb. Symp. Quant. Biol. 72, 413-420
20. Lampugnani, M. G., Corada, M., Andriopoulou, P., Esser, S., Risau, W., and Dejana, E. (1997) Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells. J. Cell Sci. 110 (Pt 17), 2065-2077
21. Kadohama, T., Akasaka, N., Nishimura, K., Hoshino, Y., Sasajima, T., and Sumpio, B. E. (2006) p38 Mitogen-activated protein kinase activation in endothelial cell is implicated in cell alignment and elongation induced by fluid shear stress. Endothelium 13, 43-50
22. Rountree, C. B., Van Kirk, C. A., You, H., Ding, W., Dang, H., VanGuilder, H. D., and Freeman, W. M. Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization. Proteome Sci. 8, 61
23. Riegman, P. H., Morente, M. M., Betsou, F., de Blasio, P., and Geary, P. (2008) Biobanking for better healthcare. Mol. Oncol. 2, 213-222
24. Scholz, B., Skold, K., Kultima, K., Fernandez, C., Waldemarson, S., Savitski, M. M., Soderquist, M., Boren, M., Stella, R., Andren, P., et al. Impact of temperature dependent sampling procedures in proteomics and peptidomics-a characterization of the liver and pancreas post mortem degradome. Mol. Cell. Proteomics 10, M900229MCP900200
25. Franzen, B., Yang, Y., Sunnemark, D., Wickman, M., Ottervald, J., Oppermann, M., and Sandberg, K. (2003) Dihydropyrimidinase related protein- 2 as a biomarker for temperature and time dependent post mortem changes in the mouse brain proteome. Proteomics 3, 1920-1929
26. Montoya, A., Beltran, L., Casado, P., Rodriguez-Prados, J. C., and Cutillas, P. R. Characterization of a TiO(2) enrichment method for label-free quantitative phosphoproteomics. Methods 54, 370-378
27. Perkins, D. N., Pappin, D. J., Creasy, D. M., and Cottrell, J. S. (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551-3567
28. Savitski, M. M., Lemeer, S., Boesche, M., Lang, M., Mathieson, T., Bantscheff, M., and Kuster, B. Confident phosphorylation site localization using the Mascot Delta Score. Mol. Cell. Proteomics 10, M110 003830
29. Vizcaino, J. A., Cote, R. G., Csordas, A., Dianes, J. A., Fabregat, A., Foster, J. M., Griss, J., Alpi, E., Birim, M., Contell, J., et al. The Proteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 41, D1063-1069
30. Cutillas, P. R., and Vanhaesebroeck, B. (2007) Quantitative profile of five murine core proteomes using label-free functional proteomics. Mol. Cell. Proteomics 6, 1560-1573
31. Huang da, W., Sherman, B. T., Tan, Q., Kir, J., Liu, D., Bryant, D., Guo, Y., Stephens, R., Baseler, M. W., Lane, H. C., et al. (2007) DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 35, W169-175
32. Casado, P., Rodriguez-Prados, J. C., Cosulich, S. C., Guichard, S., Vanhaesebroeck, B., Joel, S., and Cutillas, P. R. Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci. Signal 6, 6
33. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789
34. Cho, J. H., and Johnson, G. V. (2003) Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding. J. Biol. Chem. 278, 187-193
35. Li, T., and Paudel, H. K. (2006) Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism. Biochemistry 45, 3125-3133
36. Liberman, Z., and Eldar-Finkelman, H. (2005) Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling. J. Biol. Chem. 280, 4422-4428
37. Donahue, A. C., Kharas, M. G., and Fruman, D. A. (2007) Measuring phosphorylated Akt and other phosphoinositide 3-kinase-regulated phosphoproteins in primary lymphocytes. Methods Enzymol. 434, 131-154
38. Thoreen, C. C., Chantranupong, L., Keys, H. R., Wang, T., Gray, N. S., and Sabatini, D. M. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485, 109-113
39. Laplante, M., and Sabatini, D. M. (2009) mTOR signaling at a glance. J. Cell Sci. 122, 3589-3594
40. Ryazanov, A. G., Shestakova, E. A., and Natapov, P. G. (1988) Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation. Nature 334, 170-173
41. Hofmann, S., Cherkasova, V., Bankhead, P., Bukau, B., and Stoecklin, G. (2012) Translation suppression promotes stress granule formation and cell survival in response to cold shock. Mol. Biol. Cell 23, 3786-3800
42. Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331, 456-461
43. Hardie, D. G., Ross, F. A., and Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251-262
44. Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., and Shaw, R. J. (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214-226
45. Hawley, S. A., Davison, M., Woods, A., Davies, S. P., Beri, R. K., Carling, D., and Hardie, D. G. (1996) Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271, 27879-27887
46. Ning, J., Xi, G., and Clemmons, D. R. Suppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cells. Endocrinology 152, 3143-3154
47. Davies, S. P., Carling, D., Munday, M. R., and Hardie, D. G. (1992) Diurnal rhythm of phosphorylation of rat liver acetyl-CoA carboxylase by the AMP-activated protein kinase, demonstrated using freeze-clamping. Effects of high fat diets. Eur. J. Biochem. 203, 615-623
48. Kim, J., Kundu, M., Viollet, B., and Guan, K. L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132-141
49. Polson, H. E., de Lartigue, J., Rigden, D. J., Reedijk, M., Urbe, S., Clague, M. J., and Tooze, S. A. Mammalian Atg18 (WIPI2) localizes to omegas-ome-anchored phagophores and positively regulates LC3 lipidation. Autophagy 6, 506-522
50. Bjorkoy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Overvatn, A., Stenmark, H., and Johansen, T. (2005) p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin- induced cell death. J. Cell Biol. 171, 603-614
51. Chen, L., Monti, S., Juszczynski, P., Daley, J., Chen, W., Witzig, T. E., Habermann, T. M., Kutok, J. L., and Shipp, M. A. (2008) SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood 111, 2230-2237
52. Gamerdinger, M., Hajieva, P., Kaya, A. M., Wolfrum, U., Hartl, F. U., and Behl, C. (2009) Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3. EMBO J. 28, 889-901
53. Gibbs, E. M., Feldman, E. L., and Dowling, J. J. The role of MTMR14 in autophagy and in muscle disease. Autophagy 6, 819-820
54. Pacheco, C. D., Elrick, M. J., and Lieberman, A. P. (2009) Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis. Hum. Mol. Genet. 18, 956-965
55. Vergne, I., Roberts, E., Elmaoued, R. A., Tosch, V., Delgado, M. A., Proikas- Cezanne, T., Laporte, J., and Deretic, V. (2009) Control of autophagy initiation by phosphoinositide 3-phosphatase Jumpy. EMBO J. 28, 2244-2258
56. McKnight, N. C., Jefferies, H. B., Alemu, E. A., Saunders, R. E., Howell, M., Johansen, T., and Tooze, S. A. Genome-wide siRNA screen reveals amino acid starvation-induced autophagy requires SCOC and WAC. EMBO J. 31, 1931-1946
57. Holcik, M., and Sonenberg, N. (2005) Translational control in stress and apoptosis. Nat. Rev. Mol. Cell Biol. 6, 318-327
58. Takano, A., Usui, I., Haruta, T., Kawahara, J., Uno, T., Iwata, M., and Kobayashi, M. (2001) Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin. Mol. Cell. Biol. 21, 5050-5062
59. Hizli, A. A., Chi, Y., Swanger, J., Carter, J. H., Liao, Y., Welcker, M., Ryazanov, A. G., and Clurman, B. E. (2013) Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A-cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase. Mol. Cell. Biol. 33, 596-604
60. Browne, G. J., and Proud, C. G. (2004) A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin. Mol. Cell. Biol. 24, 2986-2997
61. Russell, R. C., Tian, Y., Yuan, H., Park, H. W., Chang, Y. Y., Kim, J., Kim, H., Neufeld, T. P., Dillin, A., and Guan, K. L. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat. Cell Biol. 15, 741-750
62. Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo- Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre- Ghiso, J. A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8, 445-544
63. Wirth, M., Joachim, J., and Tooze, S. A. Autophagosome formation-The role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage. Semin Cancer Biol. 23, 301-309
64. Hara, T., Takamura, A., Kishi, C., Iemura, S., Natsume, T., Guan, J. L., and Mizushima, N. (2008) FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J. Cell Biol. 181, 497-510
65. Backer, J. M. (2008) The regulation and function of Class III PI3Ks: novel roles for Vps34. Biochem. J. 410, 1-17
66. Kuma, A., Matsui, M., and Mizushima, N. (2007) LC3, an autophagosome marker, can be incorporated into protein aggregates independent of autophagy: caution in the interpretation of LC3 localization. Autophagy 3, 323-328
67. Bennetzen, M. V., Marino, G., Pultz, D., Morselli, E., Faergeman, N. J., Kroemer, G., and Andersen, J. S. Phosphoproteomic analysis of cells treated with longevity-related autophagy inducers. Cell Cycle 11, 1827-1840
68. Chen, Y., Yang, L. N., Cheng, L., Tu, S., Guo, S. J., Le, H. Y., Xiong, Q., Mo, R., Li, C. Y., Jeong, J. S., et al. BAG3 Interactome Analysis Reveals a New Role in Modulating Proteasome Activity. Mol. Cell. Proteomics. 12, 2804-2819
69. Levenson, A. S., and Jordan, V. C. (1997) MCF-7: the first hormoneresponsive breast cancer cell line. Cancer Res. 57, 3071-3078
70. Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 39, D945-D950
71. Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., and Pollak, M. (2006) Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res. 66, 10269-10273
72. Dowling, R. J., Zakikhani, M., Fantus, I. G., Pollak, M., and Sonenberg, N. (2007) Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res. 67, 10804-10812
73. Song, C. W., Lee, H., Dings, R. P., Williams, B., Powers, J., Santos, T. D., Choi, B. H., and Park, H. J. Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells. Sci. Rep. 2, 362
74. Shackelford, D. B., Abt, E., Gerken, L., Vasquez, D. S., Seki, A., Leblanc, M., Wei, L., Fishbein, M. C., Czernin, J., Mischel, P. S., et al. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. Cancer Cell 23, 143-158